Need a specific person's email?
Browse Belite Bio's employee directory (about 86 employees) and reveal verified emails free.
Belite Bio's most common email format is FirstLast@belitebio.com (ex. JohnDoe@belitebio.com), used for 81% of belitebio.com addresses. Belite Bio uses 3 email patterns.
| Format | Example | Share of belitebio.com |
|---|---|---|
| FirstLast@belitebio.comMost common | JohnDoe@belitebio.com | |
| FLast@belitebio.com | JDoe@belitebio.com | |
| FirLast@belitebio.com | JohDoe@belitebio.com |
Browse Belite Bio's employee directory (about 86 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States51-200 Employees
Belite Bio is a San Diego-based biotechnology research company focused on clinical-stage drug development for degenerative retinal diseases and metabolic disorders. Its lead candidate Tinlarebant (LBS-008) is an oral, once-daily tablet intended to treat early-stage dry AMD and Stargardt disease (STGD1). Tinlarebant is in Phase 3 and has received regulatory designations including US Fast Track and Rare Pediatric Disease (RPD), as well as Orphan Drug Designation in the US and from the EMA for STGD1. Belite Bio trades on the NASDAQ as BLTE and is headquartered at 5820 Oberlin Drive Suite 101, San Diego, CA 92121, United States. The company has 51-200 employees and has reported revenue in the range of $10 million to $25 million, with funding around $125 million.
Most common format
FirstLast@belitebio.com
Example: JohnDoe@belitebio.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.